226 related articles for article (PubMed ID: 21431693)
1. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
Liu YP; Westerink JT; ter Brake O; Berkhout B
Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vector engineering for anti-HIV RNAi gene therapy.
ter Brake O; Westerink JT; Berkhout B
Methods Mol Biol; 2010; 614():201-13. PubMed ID: 20225046
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
4. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
8. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
Leonard JN; Schaffer DV
J Virol; 2005 Feb; 79(3):1645-54. PubMed ID: 15650190
[TBL] [Abstract][Full Text] [Related]
9. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
Li MJ; Rossi JJ
Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
[TBL] [Abstract][Full Text] [Related]
11. Control of HIV-1 replication by RNA interference.
Lee NS; Rossi JJ
Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
[TBL] [Abstract][Full Text] [Related]
12. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
13. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
14. Silencing of HIV-1 gene expression by siRNAs in transduced cells.
Hayafune M; Miyano-Kurosaki N; Takaku H; Park WS
Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):795-9. PubMed ID: 16898417
[TBL] [Abstract][Full Text] [Related]
15. Generation of hairpin-based RNAi vectors for biological and therapeutic application.
Boudreau RL; Davidson BL
Methods Enzymol; 2012; 507():275-96. PubMed ID: 22365779
[TBL] [Abstract][Full Text] [Related]
16. Production of multicopy shRNA lentiviral vectors for antiviral therapy.
Henry SD; Pan Q; van der Laan LJ
Methods Mol Biol; 2011; 721():313-32. PubMed ID: 21431694
[TBL] [Abstract][Full Text] [Related]
17. Toward a durable treatment of HIV-1 infection using RNA interference.
Eekels JJ; Berkhout B
Prog Mol Biol Transl Sci; 2011; 102():141-63. PubMed ID: 21846571
[TBL] [Abstract][Full Text] [Related]
18. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
